← Back to Clinical Trials
Recruiting NCT05851287

NCT05851287 The Aging Eye Cohort Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05851287
Status Recruiting
Phase
Sponsor Zhongshan Ophthalmic Center, Sun Yat-sen University
Condition Eye Diseases
Study Type OBSERVATIONAL
Enrollment 2,500 participants
Start Date 2023-02-20
Primary Completion 2028-02-19

Trial Parameters

Condition Eye Diseases
Sponsor Zhongshan Ophthalmic Center, Sun Yat-sen University
Study Type OBSERVATIONAL
Phase N/A
Enrollment 2,500
Sex ALL
Min Age 60 Years
Max Age 95 Years
Start Date 2023-02-20
Completion 2028-02-19

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Aging is a major risk factor for many blind-causing eye diseases, e.g., glaucoma, age-related cataracts, and age-related macular degeneration. With the population aging, the impact of lifestyle changes (less time spent outdoors, increasingly sedentary lifestyles, and unhealthy eating habits) on the eye health of the elderly needs further research. This study focuses on establishing a cohort of elderly subjects with normal vision and ocular structure at baseline. The main goal is to study the risk factors for common eye diseases in Chinese elderly population while providing normal-controlled clinical and genomic data for other clinical studies on eye diseases.

Eligibility Criteria

Inclusion criteria: 1. Be able and willing to consent to the qualification and the follow-up phases of the study; 2. Be able to undergo yearly examinations for ≥5 years; 3. Age is older than 60 years; 4. Best-corrected visual acuity of both eyes is better than 20/32; 5. Intraocular pressure (non-contact tonometer) is between 10-21 mmHg; 6. Except for mild cataracts, no other structural abnormalities of the eye are found. 7. have fundus photographs of adequate quality as assessed with a standardized protocol by the University of Wisconsin Fundus Photograph Reading Center. Exclusion Criteria: 1. the presence of ocular disease in either eye, except for mild cataracts and ametropia; 2. previous retinal or other ocular surgical procedures (other than cataract extraction and capsulotomy); 3. a chronic requirement for any systemic or ocular medication administered for other diseases and known to be toxic to the retina or optic nerve; 4. cataract surgery within three months or capsulotomy with

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology